Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 89
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Ciani, Oriana Federici, Carlo and Tarricone, Rosanna 2016. XIV Mediterranean Conference on Medical and Biological Engineering and Computing 2016.

    Fuchs, Sabine Olberg, Britta Panteli, Dimitra and Busse, Reinhard 2016. HEALTH TECHNOLOGY ASSESSMENT OF MEDICAL DEVICES IN EUROPE: PROCESSES, PRACTICES, AND METHODS. International Journal of Technology Assessment in Health Care, p. 1.

    Fuchs, Sabine Olberg, Britta Panteli, Dimitra Perleth, Matthias and Busse, Reinhard 2016. HTA of medical devices: Challenges and ideas for the future from a European perspective. Health Policy,

    Hunger, Theresa Schnell-Inderst, Petra Sahakyan, Narine and Siebert, Uwe 2016. USING EXPERT OPINION IN HEALTH TECHNOLOGY ASSESSMENT: A GUIDELINE REVIEW. International Journal of Technology Assessment in Health Care, Vol. 32, Issue. 03, p. 131.

    Jaramillo, Hector Eduardo Castro Moreno-Mattar, Ornella and Osorio-Cuevas, Diana 2016. EMERGENCE OF “DRIVERS” FOR THE IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT. International Journal of Technology Assessment in Health Care, p. 1.

    Kaló, Zoltán Gheorghe, Adrian Huic, Mirjana Csanádi, Marcell and Kristensen, Finn Boerlum 2016. HTA Implementation Roadmap in Central and Eastern European Countries. Health Economics, Vol. 25, p. 179.

    Mantovani, Lorenzo Giovanni Cortesi, Paolo Angelo and Strazzabosco, Mario 2016. Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases. Hepatology, Vol. 64, Issue. 4, p. 1331.

    Martelli, Nicolas Hansen, Paul van den Brink, Hélène Boudard, Aurélie Cordonnier, Anne-Laure Devaux, Capucine Pineau, Judith Prognon, Patrice and Borget, Isabelle 2016. Combining multi-criteria decision analysis and mini-health technology assessment: A funding decision-support tool for medical devices in a university hospital setting. Journal of Biomedical Informatics, Vol. 59, p. 201.

    Martín-Ruiz, Eva Espín Balbino, Jaime Lemgruber, Alexandre Caro-Martínez, Araceli Lessa, Fernanda Olry-de-Labry-Lima, Antonio Pérez-Velasco, Roman and García-Mochón, Leticia 2016. Adoption of trastuzumab for breast cancer in four emerging countries in the use of health technology assessment: a case study. Journal of Comparative Effectiveness Research, Vol. 5, Issue. 4, p. 365.

    Nguyen, Timothy K. Goodman, Chris D. Boldt, R. Gabriel Warner, Andrew Palma, David A. Rodrigues, George B. Lock, Michael I. Mishra, Mark V. Zaric, Gregory S. and Louie, Alexander V. 2016. Evaluation of Health Economics in Radiation Oncology: A Systematic Review. International Journal of Radiation Oncology*Biology*Physics, Vol. 94, Issue. 5, p. 1006.

    Panayidou, Klea Gsteiger, Sandro Egger, Matthias Kilcher, Gablu Carreras, Máximo Efthimiou, Orestis Debray, Thomas P. A. Trelle, Sven and Hummel, Noemi 2016. GetReal in mathematical modelling: a review of studies predicting drug effectiveness in the real world. Research Synthesis Methods, Vol. 7, Issue. 3, p. 264.

    Rasu, Rafia S. 2016. Macro and Micro Level Usage of Outcomes Research in Pharmacy Practices. Hospital Pharmacy, Vol. 51, Issue. 5, p. 351.

    Tafuri, Giovanni Pagnini, Margherita Moseley, Jane Massari, Marco Petavy, Frank Behring, Antje Catalan, Arantxa Gajraj, Elangovan Hedberg, Niklas Obach, Mercè Osipenko, Leeza Russo, Pierluigi Van De Casteele, Marc Zebedin, Eva-Maria Rasi, Guido and Vamvakas, Spiros 2016. How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory-HTA parallel scientific advice. British Journal of Clinical Pharmacology, Vol. 82, Issue. 4, p. 965.

    Wortley, Sally Street, Jackie Lipworth, Wendy and Howard, Kirsten 2016. What factors determine the choice of public engagement undertaken by health technology assessment decision-making organizations?. Journal of Health Organization and Management, Vol. 30, Issue. 6, p. 872.

    Ciani, Oriana Wilcher, Britni Blankart, Carl Rudolf Hatz, Maximilian Rupel, Valentina Prevolnik Erker, Renata Slabe Varabyova, Yauheniya and Taylor, Rod S. 2015. HEALTH TECHNOLOGY ASSESSMENT OF MEDICAL DEVICES: A SURVEY OF NON-EUROPEAN UNION AGENCIES. International Journal of Technology Assessment in Health Care, Vol. 31, Issue. 03, p. 154.

    Kleijnen, Sarah Fathallah, Mohammed van der Linden, Michiel W. Vancraeynest, Piet Dahmani, Bachir Timoney, Angela De Boer, Anthonius Leufkens, Hubertus G. and Goettsch, Wim G. 2015. Can a Joint Assessment Provide Relevant Information for National/Local Relative Effectiveness Assessments? An In-Depth Comparison of Pazopanib Assessments. Value in Health, Vol. 18, Issue. 5, p. 663.

    Martelli, Nicolas Billaux, Mathilde Borget, Isabelle Pineau, Judith Prognon, Patrice and van den Brink, Helene 2015. INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVES. International Journal of Technology Assessment in Health Care, Vol. 31, Issue. 1-2, p. 12.

    Sampietro-Colom, Laura Lach, Krzysztof Pasternack, Iris Wasserfallen, Jean-Blaise Cicchetti, Americo Marchetti, Marco Kidholm, Kristian Arentz-Hansen, Helene Rosenmöller, Magdalene Wild, Claudia Kahveci, Rabia and Ulst, Margus 2015. GUIDING PRINCIPLES FOR GOOD PRACTICES IN HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT UNITS. International Journal of Technology Assessment in Health Care, Vol. 31, Issue. 06, p. 457.

    Fugel, Hans-Joerg Connolly, Mark and Nuijten, Mark 2014. An economic assessment of embryo diagnostics (Dx) - the costs of introducing non-invasive embryo diagnostics into IVF standard treatment practices. BMC Health Services Research, Vol. 14, Issue. 1,

    Khangura, Sara Polisena, Julie Clifford, Tammy J. Farrah, Kelly and Kamel, Chris 2014. RAPID REVIEW: AN EMERGING APPROACH TO EVIDENCE SYNTHESIS IN HEALTH TECHNOLOGY ASSESSMENT. International Journal of Technology Assessment in Health Care, Vol. 30, Issue. 01, p. 20.

  • International Journal of Technology Assessment in Health Care, Volume 24, Issue 3
  • July 2008, pp. 244-258

Key principles for the improved conduct of health technology assessments for resource allocation decisions

  • Michael F. Drummond (a1), J. Sanford Schwartz (a2), Bengt Jönsson (a3), Bryan R. Luce (a4), Peter J. Neumann (a5), Uwe Siebert (a6) and Sean D. Sullivan (a7)
  • DOI:
  • Published online: 01 July 2008

Health technology assessment (HTA) is a dynamic, rapidly evolving process, embracing different types of assessments that inform real-world decisions about the value (i.e., benefits, risks, and costs) of new and existing technologies. Historically, most HTA agencies have focused on producing high quality assessment reports that can be used by a range of decision makers. However, increasingly organizations are undertaking or commissioning HTAs to inform a particular resource allocation decision, such as listing a drug on a national or local formulary, defining the range of coverage under insurance plans, or issuing mandatory guidance on the use of health technologies in a particular healthcare system. A set of fifteen principles that can be used in assessing existing or establishing new HTA activities is proposed, providing examples from existing HTA programs. The principal focus is on those HTA activities that are linked to, or include, a particular resource allocation decision. In these HTAs, the consideration of both costs and benefits, in an economic evaluation, is critical. It is also important to consider the link between the HTA and the decision that will follow. The principles are organized into four sections: (i) “Structure” of HTA programs; (ii) “Methods” of HTA; (iii) “Processes for Conduct” of HTA; and (iv) “Use of HTAs in Decision Making.”

Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2.S Birch , A Gafni . Information created to evade reality (ICER): Things we should not look to for answers. Pharmacoeconomics. 2006;24:11211131.

3.A Brennan , SE Chick , R Davies . A taxonomy of model structures for economic evaluation of health technologies. Health Econ. 2006;15:12951310.

5.N Devlin , D Parkin . Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Econ. 2004;13:437452.

7.MF Drummond , H Weatherly . Implementing the findings of health technology assessments. If the CAT got out of the bag, can the TAIL wag the dog? Int J Technol Assess Health Care. 2000;16:112.

8.DM Eddy . Investigational treatments: How strict should we be? JAMA. 1997;278:179185.

9.DM Eddy . Evidence-based medicine: A unified approach. Health Aff (Millwood). 2005;24:917.

10.EJ Emanuel , VR Fuchs , AM Garber . Essential elements of a technology and outcomes assessment initiative. JAMA. 2007;298:13231325.

13.AM Garber . Evidence-based coverage policy. Health Aff (Millwood). 2001;20:6282.

14.LP Garrison , P Neumann , P Erickson , D Marshall , CD Mullins . Using real world data for coverage and payment decisions: The ISPOR real world task force report. Value Health. 2007;10:326335.

15.B George , A Harris , A Mitchell . Cost-effectiveness analysis and the consistency of decision making: Evidence from pharmaceutical reimbursement in Australia (1991 to 1996). Pharmacoeconomics. 2001;19:11031109.

17.R Goeree , L Levin . Building bridges between academic research and policy formulation: The PRUFE framework-an integral part of Ontario's evidence-based HTPA process. Pharmacoeconomics. 2006;24:11431156.

19.S Griffin , K Claxton , N Hawkins , MJ Sculpher . Probabilistic analysis and computationally expensive models: Necessary and required? Value Health. 2006;9:244252.

25.J Mauskopf , MF Drummond . Publication of pharmacoeconomic data submitted to reimbursement or clinical guidelines agencies (Editorial). Value Health. 2004;7:515516.

29.PJ Neumann , SD Sullivan . Economic evaluation in the US: What is the missing link? Pharmacoeconomics. 2006;24:1163–8.

30.HZ Noorani , D Husereau , R Boudreau , B Skidmore . Priority setting for health technology assessments: a systematic review of current practical approaches. Int J Technol Assess Health Care. 2007;23:310315.

32.MD Rawlins , AJ Culyer . National Institute of Clinical Excellence and its value judgments. BMJ. 2004;329:224227.

34.DL Sackett , WM Rosenberg , JA Gray , RB Haynes , WS Richardson . Evidence based medicine: What it is and what it isn't. BMJ. 1996;312:7172.

35.MJ Sculpher , MF Drummond . Analysis sans frontiers: Can we ever make economic evaluations generalisable across jurisdictions? Pharmacoeconomics. 2006;24:10871099.

36.TA Sheldon , N Cullum , D Dawson , What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients’ notes and interviews. BMJ. 2004;329:999.

37.U Siebert . When should decision-analytic modeling be used in economic evaluation of health care? Eur J Health Econ. 2003;4:143150.

38.EP Steinberg , S Tunis , D Shapiro . Insurance coverage for experimental technologies. Health Aff (Millwood). 1995;14:143158.

40.SR Tunis . Reflections on science, judgment, and value in evidence-based decision making: A conversation with David Eddy. Health Aff (Millwood). 2007;26:w500w515.

41.SR Tunis , SD Pearson . Coverage options for promising technologies: Medicare's ‘Coverage with evidence development’. Health Aff (Millwood). 2006;25:12181230.

42.SR Tunis , DB Stryer , CM Clancy . Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:16241632.

43.GR Wilensky . Developing a center for comparative effectiveness information. Health Aff (Millwood). 2006;25:w572w585.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Journal of Technology Assessment in Health Care
  • ISSN: 0266-4623
  • EISSN: 1471-6348
  • URL: /core/journals/international-journal-of-technology-assessment-in-health-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *